§ Same category · GLP-1 / metabolic peptides
CagriSema vs Tirzepatide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
CagriSema
0
vendors tracked
Tirzepatide
0
vendors tracked
CagriSema
Amylin + GLP-1 combination research stack
No current listings at 5mg.
Tirzepatide
Dual GLP-1/GIP agonist
No current listings at 10mg.
About CagriSema
A combination of cagrilintide and semaglutide in late-stage clinical development for obesity. Research-compound version mirrors the clinical dose ratio.
About Tirzepatide
A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.